{"name":"HeartDrug Research LLC","slug":"heartdrug-research-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Aliskiren + Valsartan","genericName":"Aliskiren + Valsartan","slug":"aliskiren-valsartan","indication":"Hypertension","status":"marketed"}]}],"pipeline":[{"name":"Aliskiren + Valsartan","genericName":"Aliskiren + Valsartan","slug":"aliskiren-valsartan","phase":"marketed","mechanism":"Aliskiren and valsartan work together to lower blood pressure by blocking the renin-angiotensin-aldosterone system at two different points: aliskiren directly inhibits renin, while valsartan blocks angiotensin II receptors.","indications":["Hypertension"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE92ZGE3SnN0anYxc2JhLUotSW1EQzZoNHhJdV95UU5EdVBqZTY1cXlIVUZQR0tTc3BDWHliVWN5bXdwRS0wQ2FLOWtFelNlTk1yRGF0bHRxdTBjM1NNb0x3dTBYWVFvQkE?oc=5","date":"2025-07-31","type":"pipeline","source":"MedPage Today","summary":"Heart Drug From Nearly-Forgotten Class May Treat Alzheimer's - MedPage Today","headline":"Heart Drug From Nearly-Forgotten Class May Treat Alzheimer's","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE5peU90aHVUSVJBZllUZzJkWWZ6RGVHWElhakxuenhZcEFUOVFBdG1XNkc2Z1Y1bnQxU1kzU0F5RGZ1aExiS3BzeGc1dll6YVBlTjI4SDQ5U3JUeC1TYllVRWtQSmF5UG1iU2xyUUY3dm5ILWxlOEJGbmRWbUpudw?oc=5","date":"2025-07-01","type":"deal","source":"Investor's Business Daily","summary":"Heart Drug Stock Rockets 20% On Sales, Boosts Outlook; Regeneron Pharma's Global Partnership Is Strong Tailwind - Investor's Business Daily","headline":"Heart Drug Stock Rockets 20% On Sales, Boosts Outlook; Regeneron Pharma's Global Partnership Is Strong Tailwind - Invest","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxNUWl0azY4UVVISnZqamQyMzhEWTVySXZ0eWlPOFNNazhFTnJKWHlFd0l3aUMtTTBsbEVISm11RG1wR19PWXliVHZydGtQZUNDdEhiRzE2SWNfTXRqMnNWSFFPUE5wTzBWUzRtVFJMX2tCcTh6OUZlRW1uNXFvLWQzcVdVVzJLQ0dySkdlTjV3dTh1dzBsbWt5RkhPRm84VF9fdzh3S0JOdzFteXJLTnhNeTVNa040OTltTjNDS2VDOS1Ndk1Qa1Rj?oc=5","date":"2024-11-19","type":"pipeline","source":"Fierce Biotech","summary":"Lilly's lipoprotein-blocking heart med posts midstage win, turning up heat on potential AZ showdown - Fierce Biotech","headline":"Lilly's lipoprotein-blocking heart med posts midstage win, turning up heat on potential AZ showdown","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQdFdUZUYwWGR2RnlFVkJGOWdnem1zb1RDcGp4YWlMRXUzV01rNTJmUDNlb0xGRm1RNHNOcEZhNUN4cTJ1NFotRjJxNm1nQU5lazlxVlRmQ25HZTN4bUFOQjlQZU5jZWUwd3AxV1pSNlNxSktvdFdZZWZWekx1cU1KNTZHTlp6TWVWVTk0SHROMjFxUmZQNmc5YmZPWlpMWE0?oc=5","date":"2023-08-11","type":"pipeline","source":"Bloomberg Law News","summary":"Pfizer, Scripps Sue to Block Copy of ‘Most Expensive’ Heart Drug - Bloomberg Law News","headline":"Pfizer, Scripps Sue to Block Copy of ‘Most Expensive’ Heart Drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQQUFCcV9HcVM0cGlIUDQxdk1YZF9IcHBDOXJ5NkJOU3RMVmtSWVhiNXZPM3JSZGNvUkRTUWptUFFmaG55WWRSd0Z2VS1Od2Q5VExYZ21PMVZJUE1oOVRMb09xYnUtWU94VjRXS1FZS2xEOEdvQWVfOFhZeTlDYnlfcms4RlVOTWRsakJGV21ZT2ZZQkpxbk9KR1pkM3B5S1BfWFktdG53b3ZPeWdDalMzbzU1M2pLM3N1cUV6bjFKWFc2Zw?oc=5","date":"2022-11-07","type":"trial","source":"Fierce Biotech","summary":"With new data in hand, Amgen plans to take heart drug into phase 3 to challenge Novartis - Fierce Biotech","headline":"With new data in hand, Amgen plans to take heart drug into phase 3 to challenge Novartis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOWnRrQ3RtYzdIWHNRUVVLMXI2ZVg5ZmlpNzBYSzBaNzByVy1QZEhaek8zWXNOWGVlcXJJZlhzT2RVZHpsel93OWNyVkxCanNYTlpFd0RrWi1COVhoTnpUTHBXVGM2WnFmbTNtNE9fT2xzY1ZRT25JVzNkZnYyWnVDQWY1eWt0TDByaGV5TlpqZVhIUnQwTXBfUEJ1RzJEdVJvRlRDSXlNQjdDWEtlUnZIVm5n?oc=5","date":"2022-06-01","type":"trial","source":"Fierce Biotech","summary":"Amgen's heart drug reduces cardiovascular disease risk factor in phase 2 trial - Fierce Biotech","headline":"Amgen's heart drug reduces cardiovascular disease risk factor in phase 2 trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQTVltUXRkQkVocEdvWDFLQXNPVGJIemRUemZybTRmY05nRlktRmF5QVFDU004WUlybVRUd003aUgxNVY2SmFkYWFaWGZtWTZDV2R4TERSZW01VDdJSDVTdDhWMWNiMW4ySVdWc2pXVWJtVV9yRF9lRm9nY01yaGg5R3B0QW13bU9kazJhZzBXblVJaDFCa1RLclZtQlJ4VWtRZUZLX0Z0N2xKaW0zdFE?oc=5","date":"2017-01-19","type":"trial","source":"propublica.org","summary":"When a Study Cast Doubt on a Heart Pill, the Drug Company Turned to Tom Price - propublica.org","headline":"When a Study Cast Doubt on a Heart Pill, the Drug Company Turned to Tom Price","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPSnhLQkN2a1VfN0U1VERFQlhUaG9XamNxS1RzSUQzOW41eHgtQy1qTjlNOUtadTdaVzZQSXhPNTV2dGNqZ0hScFhtWm1LRU1NTklnZkswTDdSY0VHamw2UklOdW93Y0ZSMWRtaUtHQVZncXRQbTF5M25HRGtjdlF1VkVwbDZ0SHlRMTVlSl93MVR5aHhU0gGaAUFVX3lxTE9OVU96VUVpemZ1U3dpVUtoc0g0XzJOd29QaDBqU1o4RUx2SmU3YlE5YnphU1NfTTMya29BSUtVeE1zTkJUbkd6RC1wbTdGYm9TTkdkaE5kcjQ3ek5mYW1FMEJ6eDVid1ZTa1QxUnJTVHRYNGJGRUtsTXpHa2x1OVhfTS1fREl5UGs3WmRxV1c4ZUNuTDF2VldTRHc?oc=5","date":"2013-11-12","type":"trial","source":"CNBC","summary":"GlaxoSmithKline heart drug misses goal in major study - CNBC","headline":"GlaxoSmithKline heart drug misses goal in major study","sentiment":"negative"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}